Works matching IS 14642662 AND DT 2011 AND VI 12 AND IP 2

Results: 9

Waist circumference and body mass index in HIV infection.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 124, doi. 10.1111/j.1468-1293.2010.00852.x
By:
- De Socio, G. V. L.;
- Ricci, E.;
- Bonfanti, P.;
- Quirino, T.;
- Schillaci, G.
Publication type:
Article
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 97, doi. 10.1111/j.1468-1293.2010.00856.x
By:
- Hsu, H. E.;
- Rydzak, C. E.;
- Cotich, K. L.;
- Wang, B.;
- Sax, P. E.;
- Losina, E.;
- Freedberg, K. A.;
- Goldie, S. J.;
- Lu, Z.;
- Walensky, R. P.
Publication type:
Article
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 109, doi. 10.1111/j.1468-1293.2010.00860.x
By:
- Gianotti, N.;
- Visco, F.;
- Galli, L.;
- Barda, B.;
- Piatti, P.;
- Salpietro, S.;
- Bigoloni, A.;
- Vinci, C.;
- Nozza, S.;
- Gallotta, G.;
- Lazzarin, A.;
- Castagna, A.
Publication type:
Article
Can antiretroviral therapy be safely interrupted and, if so, when?
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 126, doi. 10.1111/j.1468-1293.2010.00853.x
By:
- Lattuada, E.;
- Lanzafame, M.;
- Vento, S.
Publication type:
Article
Pregnancy in HIV-infected teenagers in London.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 118, doi. 10.1111/j.1468-1293.2010.00878.x
By:
- Elgalib, A.;
- Hegazi, A.;
- Samarawickrama, A.;
- Roedling, S.;
- Tariq, S.;
- Draeger, E.;
- Hemelaar, J.;
- Rathnayaka, T.;
- Azwa, A.;
- Hawkins, D.;
- Edwards, S.;
- Perez, K.;
- Russell, J.;
- Wood, C.;
- Poulton, M.;
- Shah, R.;
- Noble, H.;
- Rodgers, M.;
- Taylor, G. P.;
- Anderson, J.
Publication type:
Article
The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 65, doi. 10.1111/j.1468-1293.2010.00848.x
By:
- Carsenti-Dellamonica, H.;
- Saïdi, H.;
- Ticchioni, M.;
- Guillouet de Salvador, F.;
- Dufayard Cottalorda, J.;
- Garraffo, R.;
- Dellamonica, P.;
- Durant, J.;
- Gougeon, M.-L.
Publication type:
Article
ERRATUM.
Published in:
2011
Publication type:
Correction Notice
Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 78, doi. 10.1111/j.1468-1293.2010.00849.x
By:
- Baum, M. K.;
- Sales, S.;
- Jayaweera, D. T.;
- Lai, S.;
- Bradwin, G.;
- Rafie, C.;
- Page, J. B.;
- Campa, A.
Publication type:
Article
Doctor-patient concordance during HIV treatment switching decision-making.
Published in:
HIV Medicine, 2011, v. 12, n. 2, p. 87, doi. 10.1111/j.1468-1293.2010.00851.x
By:
- Clucas, C.;
- Harding, R.;
- Lampe, F. C.;
- Anderson, J.;
- Date, H. L.;
- Johnson, M.;
- Edwards, S.;
- Fisher, M.;
- Sherr, L.
Publication type:
Article